Precision BioSciences, Inc.

DTIL

$5.42

Name : Precision BioSciences, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $134,018,696.00

EPSttm : -3.63

Precision BioSciences, Inc.

$5.42

9.97%

$0.6

DTIL — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

7.23

Margin Of Safety %

Put/Call OI Ratio

0.03

EPS Next Q Diff

-1.28

EPS Last/This Y

0.03

EPS This/Next Y

0.13

Price

5.44

Target Price

Analyst Recom

Performance Q

28.13

Upside

-1,342.4%

Beta

0.9

Ticker: DTIL

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	DTIL	4.33	0.01	0.00	2098
2026-03-03	DTIL	4.34	0.01	0.00	2100
2026-03-04	DTIL	4.78	0.01	0.00	2104
2026-03-05	DTIL	4.52	0.01	0.00	2105
2026-03-06	DTIL	4.61	0.01	0.00	2103
2026-03-09	DTIL	4.71	0.01	0.24	2104
2026-03-10	DTIL	5.35	0.03	2.50	2289
2026-03-11	DTIL	5.06	0.03	0.11	2311
2026-03-12	DTIL	5.66	0.04	0.27	2317
2026-03-13	DTIL	5.67	0.04	0.27	2317
2026-03-17	DTIL	6.91	0.03	0.00	2337
2026-03-18	DTIL	7.01	0.03	0.08	2344
2026-03-19	DTIL	6.7	0.03	0.07	2344
2026-03-20	DTIL	6.5	0.03	0.00	2344
2026-03-23	DTIL	6.49	0.03	0.00	894
2026-03-24	DTIL	6.41	0.03	0.00	896
2026-03-25	DTIL	6.46	0.03	0.36	898
2026-03-26	DTIL	6.52	0.03	0.33	913
2026-03-27	DTIL	6.03	0.03	0.33	913
2026-03-30	DTIL	5.45	0.03	5.00	917
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	DTIL	4.33	69.9	-	-6.16
2026-03-03	DTIL	4.36	69.9	-	-6.16
2026-03-04	DTIL	4.78	69.9	-	-6.16
2026-03-05	DTIL	4.53	69.9	-	-6.16
2026-03-06	DTIL	4.61	69.9	-	-6.16
2026-03-09	DTIL	4.71	69.9	-	-6.16
2026-03-10	DTIL	5.34	69.9	-	-6.16
2026-03-11	DTIL	5.07	69.9	-	-6.16
2026-03-12	DTIL	5.64	69.9	-	-6.16
2026-03-13	DTIL	5.67	69.9	-	-6.16
2026-03-17	DTIL	6.93	69.9	-	-6.16
2026-03-18	DTIL	7.05	69.9	-	-6.16
2026-03-19	DTIL	6.70	69.9	-	-6.16
2026-03-20	DTIL	6.51	63.8	-	-3.53
2026-03-23	DTIL	6.51	63.8	-	-3.53
2026-03-24	DTIL	6.41	63.8	-	-3.53
2026-03-25	DTIL	6.47	63.8	-	-3.53
2026-03-26	DTIL	6.52	63.8	-	-3.53
2026-03-27	DTIL	6.03	63.8	-	-3.53
2026-03-30	DTIL	5.44	63.8	-	-3.53
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	DTIL	-1.90	45.35	7.89
2026-03-03	DTIL	-1.90	45.35	7.89
2026-03-04	DTIL	-1.90	45.35	7.89
2026-03-05	DTIL	-1.90	45.35	7.89
2026-03-06	DTIL	-1.90	45.35	7.89
2026-03-09	DTIL	-1.90	45.35	7.89
2026-03-10	DTIL	-1.90	45.35	7.89
2026-03-11	DTIL	-1.90	45.35	7.36
2026-03-12	DTIL	-1.90	45.35	7.36
2026-03-13	DTIL	-1.90	45.35	7.36
2026-03-17	DTIL	-1.85	40.64	7.17
2026-03-18	DTIL	-1.85	40.64	7.17
2026-03-19	DTIL	-1.85	40.64	7.17
2026-03-20	DTIL	-1.85	40.64	7.17
2026-03-23	DTIL	-1.85	40.60	7.17
2026-03-24	DTIL	-1.85	40.60	7.17
2026-03-25	DTIL	-1.87	40.60	7.23
2026-03-26	DTIL	-1.87	40.60	7.23
2026-03-27	DTIL	-1.87	40.60	7.23
2026-03-30	DTIL	-1.87	40.60	7.23
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.36

Avg. EPS Est. Current Quarter

-0.8

Avg. EPS Est. Next Quarter

-0.92

Insider Transactions

-1.87

Institutional Transactions

40.6

Beta

0.9

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.7

Max Drawdown 5-Year %

-99.2

Target Price

P/E

Forward P/E

PEG

P/S

3.91

P/B

1.42

P/Free Cash Flow

EPS

-5.18

Average EPS Est. Cur. Y

-3.53

EPS Next Y. (Est.)

-3.4

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-136.03

Relative Volume

0.92

Return on Equity vs Sector %

-77

Return on Equity vs Industry %

-60.7

EPS 1 7Days Diff

-0.4

EPS 1 30Days Diff

-0.42

EBIT Estimation

◆ DTIL Healthcare

$5.42

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

2/20

Pullback

9/25

Volume

7/15

Valuation

12/20

TP/AR

2/10

Options

5/10

RSI

47.9

Range 1M

40.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

19/30

Estimates

0/20

Inst/Vol

10/15

Options

6/10

EPS Yr

17.4%

EPS NY

6.5%

52W%

36.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +490.4% upside

Quality

6/30

Valuation

16/30

Growth

13/25

Stability

7/10

LT Trend

1/5

Upside

+490.4%

Quality

Precision BioSciences, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 68

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-DMD (Excision) for the treatment of Duchenne muscular dystrophy. In addition, the company develops PBGENE-3243 for the treatment of m.3243 associated mitochondrial diseases; and iECURE-OTC (Insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azercabtagene zapreleucel for autoimmune diseases and other indications; and iECURE, Inc., an ARCUS-mediated targeted gene insertion. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.

DTIL

Latest News

—

Caricamento notizie per DTIL…

stock quote shares DTIL – Precision BioSciences Inc. Stock Price stock today

news today DTIL – Precision BioSciences Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DTIL – Precision BioSciences Inc. yahoo finance google finance

stock history DTIL – Precision BioSciences Inc. invest stock market

stock prices DTIL premarket after hours

ticker DTIL fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: DTIL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y